?
Boxer Michael A
SVP and General Counsel
Thermo Fisher Scientific Inc.
US, Waltham [HQ]
CIK
1726596
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
13,083,172
Price per Share :
$561.65
Equivalence :
$7,348,163,553.80
Transaction History
-
F13,083,172 Shares After TransactionValue : $7,483,966,879.16$166,499,628.04Transaction Date : 02/28/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
F12,938,122 Shares After TransactionValue : $7,842,054,506.64$8,791,770.60Transaction Date : 08/23/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
F1,337,424 Shares After TransactionValue : $755,256,707.04$135,427,058.07Transaction Date : 02/23/24
-
Footnotes
-
-
Footnotes:#1 Reflects a downward adjustment of 88 shares of a performance-based restricted stock unit award granted on February 23, 2021. On February 23, 2022, the reporting person reported the acquisition of the performance-based restricted stock unit award. One-third of the shares vested on February 23, 2022, one-third of the shares vested on February 23, 2023, and the remaining one-third vested on February 23, 2024, subject to adjustment based on the Company's relative total shareholder return ("TSR") over the measurement period starting on January 1, 2021, through to December 31, 2023. As a result of the Company's relative TSR, the third tranche was adjusted downward by 15%. As such, the reporting person received 88 less shares than the amount initially reported.
-
G12,545,534 Shares After TransactionValue : $n/a$0.0Transaction Date : 12/05/24
-
Footnotes
-
-
Footnotes:#1 Bona fide gift by the reporting person of 190 shares to a donor-advised fund. Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.
-
M14,735,534 Shares After TransactionValue : $3,104,482,303.12$421,360.00Transaction Date : 10/25/24
-
Footnotes
-
-
Footnotes:#1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2023.